Department of Gastroenterology and Metabolism, Graduate School of Biomedical and Health Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.
Research Center for Hepatology and Gastroenterology, Hiroshima University, Hiroshima, Japan.
J Gastroenterol. 2019 Jul;54(7):650-659. doi: 10.1007/s00535-019-01558-w. Epub 2019 Feb 21.
The clinical course and responsiveness to antiviral treatments differs among hepatitis B virus (HBV) genotypes. However, the cause of these differences is unclear. In the present study, we compared mRNA expression profiles in human hepatocyte chimeric mice infected with HBV genotypes A and C.
Fifteen chimeric mice were prepared and divided into the following three groups: uninfected control mice, HBV genotype A-infected mice, and HBV genotype C-infected mice. Human hepatocytes were collected from these mouse livers and gene expression analyses were performed using next-generation RNA sequencing.
Although similar pathways were influenced by HBV infection, including inflammation mediated by chemokine and cytokine signaling, p53, and integrin signaling pathways, expression levels of up-regulated genes by HBV genotype A or C infection were quite different. In HBV genotype A-infected hepatocytes, 172 genes, including KRT23 and C10orf54, were significantly more highly expressed than in HBV genotype C-infected cells, whereas 10 genes, including SPX and IER3, were expressed at significantly lower levels. Genes associated with the p53 pathway and the inflammation mediated by chemokine and cytokine signaling pathway were more highly expressed in cells with HBV genotype A infection, whereas genes associated with CCKR signaling map and oxidative stress response were more highly expressed in cells with HBV genotype C infection.
Several differences in gene expression with respect to HBV genotype A and C infection were detected in human hepatocytes. These differences might be associated with genotypic difference in the clinical course or responsiveness to treatment.
乙型肝炎病毒(HBV)基因型的临床病程和对抗病毒治疗的反应性存在差异。然而,造成这些差异的原因尚不清楚。本研究比较了感染 A 型和 C 型 HBV 的人源肝细胞嵌合小鼠的 mRNA 表达谱。
制备了 15 只嵌合小鼠,并将其分为以下三组:未感染对照小鼠、HBV 基因型 A 感染小鼠和 HBV 基因型 C 感染小鼠。从这些小鼠的肝脏中收集人肝细胞,并使用下一代 RNA 测序进行基因表达分析。
尽管 HBV 感染影响了相似的通路,包括趋化因子和细胞因子信号转导、p53 和整合素信号通路介导的炎症,但 A 型或 C 型 HBV 感染上调基因的表达水平差异很大。在 HBV 基因型 A 感染的肝细胞中,有 172 个基因(包括 KRT23 和 C10orf54)的表达水平明显高于 HBV 基因型 C 感染的细胞,而 10 个基因(包括 SPX 和 IER3)的表达水平明显较低。与 p53 通路和趋化因子和细胞因子信号转导介导的炎症相关的基因在感染 A 型 HBV 的细胞中表达更高,而与 CCKR 信号通路和氧化应激反应相关的基因在感染 C 型 HBV 的细胞中表达更高。
在人源肝细胞中,检测到了与 HBV 基因型 A 和 C 感染相关的几个基因表达差异。这些差异可能与临床病程或治疗反应的基因型差异有关。